Analysts See $0.44 EPS for AstraZeneca PLC (AZN)

Marco Green
April 17, 2018

The institutional investor held 896,771 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $31.12 million, up from 740,671 at the end of the previous reported quarter.

AstraZeneca PLC discovers, develops, makes, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide.The firm is worth $88.62 billion. However, its trading capacity stayed around 4.27 million shares in normal days. AZN underperformed the S&P500 by 2.52%.

Goodman Financial Corp decreased its stake in Amazon Com Inc Com (AMZN) by 6.83% based on its latest 2017Q4 regulatory filing with the SEC. Martin Currie Ltd sold 39,839 shares as the company's stock declined 3.81% with the market. With approx. 2.53 billion shares in outstanding, the company has a market cap of $91962.24 as per the current valuation.

AstraZeneca plc (LON:AZN) traded down 0.1049% during mid-day trading on Tuesday, hitting GBX 4767.1772. About 3.43M shares traded. MGIC Investment Corporation (NYSE:MTG) has risen 30.58% since April 16, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Since December 7, 2017, it had 0 buys, and 13 insider sales for $45.88 million activity. Caisse De Depot Et Placement Du Quebec invested in 556,891 shares or 0.15% of the stock.

Although earnings from JPMorgan Chase and other large banks bested analyst expectations, the sector had risen in anticipation of the reports and the results - while good - were not strong enough to propel the stocks higher, analysts said. The ex-dividend date is Thursday, February 16th. Payden & Rygel reported 1,400 shares stake. The share price has already crossed its 20 days moving average, floating at a distance of 3.5% and sits 5.51% higher versus its 50 days moving average.

Investors sentiment decreased to 1.15 in Q4 2017. Its up 0.03, from 1.26 in 2017Q3. It is negative, as 69 investors sold Monday shares while 328 reduced holdings. 101 funds opened positions while 349 raised stakes. 317.44 million shares or 1.24% less from 321.42 million shares in 2017Q3 were reported. When it comes to P/B Ratio, it is basically known as a ratio that can be used to compare the market value of a stock to its book value. Stonebridge Limited Liability Company reported 26,678 shares. Mcf Advisors Limited Company has invested 0.01% of its portfolio in Monsanto Company (NYSE:MON). Neuberger Berman Limited Liability Corp holds 0% of its portfolio in National Fuel Gas Company (NYSE:NFG) for 18,089 shares. Hamilton Point Invest Advsrs Ltd Co invested in 0.13% or 836 shares. (NASDAQ:AMZN). Vgi Prns Pty Ltd reported 83,865 shares. Rand Wealth Lc stated it has 15,739 shares or 0.2% of all its holdings. (NASDAQ:AAPL) for 532,510 shares. Cohen Steers Inc invested 0.01% of its portfolio in MGIC Investment Corporation (NYSE:MTG). Bb&T accumulated 9,694 shares. (NYSE:TJX). Wms Ptnrs Llc, Maryland-based fund reported 10,515 shares. "Buy" rating has 6, "Sell" are 0, while 2 are "Hold". Therefore 48% are positive. had 282 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has an average rating of "Hold" and a consensus price target of GBX 5,008.36 ($61.26). The firm has "Neutral" rating given on Friday, May 12 by Credit Suisse. As per Friday, January 5, the company rating was downgraded by Bank of America. The firm has "Hold" rating given on Monday, November 28 by Evercore. The stock has "Buy" rating by J.P. Morgan on Friday, July 28. Muhlenkamp & Co Inc bought 67,101 shares as the company's stock declined 19.30% with the market. On Monday, October 23 the firm has "Market Perform" rating by Leerink Swann given.

Analysts await Apple Inc. AZN's profit would be $1.07B giving it 20.64 P/E if the $0.44 EPS is correct. The expected future increase in earnings per share ("EPS") is an incredibly important identifying an under-valued stock. Valeo Financial Advisors LLC acquired a new stake in AstraZeneca during the third quarter valued at approximately $133,000. Therefore 31% are positive.

AstraZeneca plc (LON:AZN) has been assigned a GBX 3,900 ($47.70) price objective by equities research analysts at Goldman Sachs Group Inc in a research report issued to clients and investors on Tuesday. Presently, AstraZeneca PLC (NYSE:AZN) has a 14-day Commodity Channel Index (CCI) of 91.39. Below is a list of AstraZeneca PLC (LON:AZN) latest ratings and price target changes. The firm earned "Overweight" rating on Friday, December 29 by JP Morgan. Zacks Investment Research lowered shares of AstraZeneca from a "hold" rating to a "sell" rating in a research note on Wednesday, January 3rd. As per Thursday, July 23, the company rating was upgraded by Jefferies.

Other reports by Click Lancashire

Discuss This Article